Neocis reaches first commercial milestone for Yomi surgical system
MIAMI, U.S.: Neocis, the leader and innovator in dental implant surgery utilizing advanced robotics, announced recently that it has reached its first U.S. commercialization milestone with the sale of its 20th Yomi—the world’s first robot-assisted dental surgical system.
“Following FDA clearance, we launched the ‘Pioneer Program’ in the U.S. to attract early adopters. I’m extremely pleased with the commercial adoption this program received, enabling us to execute our 20-system sales goal prior to our expected timeline,” said Dr. Alon Mozes, CEO of Neocis.
Yomi systems purchased under this program were placed with a wide range of customers, including oral surgeons, periodontists and general dental practitioners. “Incorporating Yomi has forever changed the way I place implants. It’s a new level of precision and the next evolution in implant dentistry. Minimally invasive, robot-assisted surgery will soon be the new standard of care in implantology,” said Dr. Eddie Kotary.
More than 4 million dental implants are placed each year in the U.S. Yet, according to Neocis, conventional surgical and drill guides fail to address many procedural challenges, such as invasive incisions and nerve damage from misplaced implants. In addition, there is a trend towards general dentists performing dental implant surgeries.
Neocis’ Yomi surgical system provides the critical planning and guidance features that provide dental surgeons with the ability to gain real-time visual feedback and physical haptic guidance, which enables a minimally invasive, flapless approach, the company said. Yomi offers surgical guidance through the use of haptic robotic technology, software and multisensory feedback to help achieve the right position, angulation and depth to place the implant exactly according to plan.